Elsevier

Behavioural Brain Research

Volume 331, 28 July 2017, Pages 84-91
Behavioural Brain Research

Research report
Behavioural outcomes of adult female offspring following maternal stress and perinatal fluoxetine exposure

https://doi.org/10.1016/j.bbr.2017.05.029Get rights and content

Highlights

  • Behaviour of female mice perinatally exposed to fluoxetine and stress was examined.

  • Maternal intake of fluoxetine improves spatial memory in female offspring.

  • Maternal stress leads to hyperactivity and an increase in prepulse inhibition.

  • Maternal fluoxetine intake does not worsen or reverse maternal stress effects.

Abstract

Depression, anxiety, and stress are common in pregnant women. One of the primary pharmacological treatments for anxiety and depression is the antidepressant fluoxetine (Flx). Maternal stress, depression, and Flx exposure are known to effect neurodevelopment of the offspring, however, their combined effects have been scarcely studied, especially in female offspring. The present study investigated the combined effects of maternal stress during pregnancy and perinatal exposure to Flx on the behaviour of female mice as adults.

Methods

Mouse dams were exposed to either chronic unpredictable stress (embryonic (E) day 7 to E18), or FLX (E15- postnatal day 12), or a combination of stress and FLX or left untreated. At two months of age, the female offspring went through a comprehensive behavioural test battery.

Results

Maternal stress led to increased activity and alterations of prepulse inhibition in the adult female offspring. Maternal treatment with Flx had a potentially beneficial effect on spatial memory. The combination of prenatal stress and perinatal Flx exposure did not interact in their effects. These results suggest that gestational Flx exposure may have a limited negative impact on female offspring.

Introduction

Stress-related disorders such as depression and anxiety are common in pregnant women: 10–18% of pregnant women present with symptoms of depression, and 6–14% present with symptoms of anxiety disorders [1], [2], [3], [4]. This prevalence is even higher in pregnant women with lower socioeconomic status due to, in part, increased frequency of stressful life events [5], [6], [7], [8]. Depression is a very stressful experience, it impacts a woman's sleep, eating, and self-care and the level of care she can provide to her child. Stress, depression, and anxiety during pregnancy can also lead to adverse obstetric outcomes and affect fetal and neonatal development and behaviour [9], [10].

Primary pharmacological treatments for anxiety and depression are selective serotonin reuptake inhibitors (SSRIs) [11]. Out of the 6% of pregnant women who are prescribed an SSRI at some point during their pregnancy, between 20 and 25% will receive fluoxetine (Flx; brand names Prozac, Sarafem, Rapiflux) [12].

Maternal intake of antidepressants and maternal anxiety, depression, and stress can affect obstetric outcomes and child's development and behaviour. Early exposure to these environmental events are linked with a decrease in gestational length and a reduction in birth weight [13], [14], [15], and may lead to changes in emotional behaviour, including anxiety, in children [16], [17]. Beyond the childhood years, effects of maternal anxiety, depression, and stress and maternal Flx exposure are not yet fully understood. Animal studies have been essential in uncovering these effects [18,19][for a review see 18, 19].

Animal studies utilize maternal stress as a model of maternal depression and anxiety. Studies show that maternal stress and maternal exposure to Flx both have long-term effects on the mouse and rat offspring. These maternal experiences alter offspring's learning and memory (stress: [20], [21], [22], [23], [24], [25]; Flx: [26], [27], [28]), aggression levels (stress: [29], [30], [31], [32]; Flx: [28], [32], [33], [34]), circadian behaviours (stress: [35]; Flx: [36]), and depressive- and anxiety-like behaviours (stress: [25], [37], [38], [39]; Flx: [26], [27], [28], [40], [41], [42], [43]).

While necessary, examining the offspring of healthy animals is of minor ethological validity when attempting to draw inferences about exposed humans. This is because Flx exposure in humans does not typically happen in isolation; Flx exposure is concurrent with maternal stress, anxiety, and/or depression. Animal studies are beginning to examine combined effects of perinatal stress and Flx exposure on adult offspring outcomes. Some studies demonstrate that Flx and stress have specific long-term effects on the offspring. They have distinct effects on reproductive behaviour [44], [45], sexual brain differentiation [44], and depressive-like behaviour [46] in rats, and anxiety-like behaviour [32], [46] and hippocampal and cortical BDNF signaling in rats and mice [32], [46]. Other studies demonstrate that while maternal exposure to stress and Flx can have distinct effects, treatment with Flx early in life can counteract some of the effects of maternal stress. In mice, these include alterations in spatial learning [47], HPA-axis reactivity [48], aggressive behaviours [32], and circadian behaviours [35], while in rats, it includes sensitivity to post-operative pain [49]. In both rodent models, Flx counteracts stress-induced alterations in hippocampal morphology [47], [50]. However, most behavioural studies were conducted in male offspring; behaviours of adult female offspring have not yet been examined aside from reproductive [45] and depressive-like behaviours of rats [46]. A thorough assessment of outcomes in female offspring is warranted. Past studies provided indications that outcomes of female offspring may differ from that of males. First, behavioural baselines show sexual dimorphism [51], [52], [53]. Second, male and female animals are differently affected by stress [54], [55], [56], [57] and Flx administration [58], [59], [60]. And, most importantly, male and female mice show different patterns of behavioural changes following maternal stress [22], [23], [61], [62], [63], [64], [65] and perinatal Flx administration [43], [63], [66].

The goal of the present study was to investigate the effects of prenatal stress and effects of perinatal exposure to Flx, separately and in combination, on the behaviour of the adult female offspring. This study sought to provide a more complete insight by conducting an in-depth behavioural analysis of the offspring's cognitive ability, memory, anxiety, sensorimotor information processing, and exploratory and risk assessment behaviours.

Section snippets

Animals

All mice were kept on a 12:12-h light/dark (LD, 1500 lx/0 lx) and were provided ad libitum access to food (LabDiet Mouse Diet 9F, #5020) and water throughout the experiment with the exception of stress manipulation measures (see below). Animal treatment and husbandry were performed in accordance with the Canadian Council on Animal Care. All experimental procedures were approved by the Ethics Committee for Animal Research at the University of Calgary.

C57BL/6 breeders were obtained from the

Actual dose of fluoxetine

Increased water consumption throughout pregnancy and lactation resulted in an actual mean Flx dose of 27.42 ± .55 mg/kg/day, instead of intended 25 mg/kg/day. Administered Flx dosage did not significantly differ between FLX and FLX + PS groups, and there was no significant group by day interaction.

Fluoxetine and norfluoxetine in pup brains

In the P12 offspring that were exposed to fluoxetine, the mean brain fluoxetine level was 0.361 ± 0.06 μg/g and the overall brain level of NorFlx was 3.73 ± 0.33 μg/g. There was no significant

Discussion

Here, we show that chronic unpredictable maternal stress leads to increased activity and alterations of PPI in the adult female mouse offspring. We also demonstrate that perinatal maternal fluoxetine treatment appears to have little effect on female mice in the behavioural test we have used, potentially having beneficial effects on spatial memory. We further show that the combination of prenatal stress and perinatal Flx exposure did not interact in their effects. We have previously demonstrated

Conclusion

Due to the high percentage of pregnant women that take Flx, it is important to understand the effect this medication alone, and in combination with maternal stress and depression, has on the offspring. Few studies examine combined effects of stress and Flx, and most of the studies that exist examine only the outcomes of male offspring. In the present study, we report that maternal stress has a number of long-lasting, potentially negative, effects on female mouse offspring. We also report that

Competing interests

The authors declare that no competing interests exist. The authors have full control of all primary data and agree to allow the journal to review their data if requested

Acknowledgement

This work was supported by NSERC Discovery and CIHR Operating grants to RHD, an NSERC and AIHS graduate scholarship to VK and a CIHR summer studentship to SM.

References (96)

  • V. Kiryanova et al.

    Effects of maternal stress and perinatal fluoxetine exposure on behavioral outcomes of adult male offspring

    Neuroscience

    (2016)
  • K. Miyagawa et al.

    Prenatal stress induces anxiety-like behavior together with the disruption of central serotonin neurons in mice

    Neurosci. Res.

    (2011)
  • N.N. Karpova et al.

    Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice

    Eur. Neuropsychopharm.

    (2009)
  • I. Rayen et al.

    Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring

    Psychoneuroendocrinology

    (2013)
  • F. Boulle et al.

    Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring

    Horm. Behav.

    (2016)
  • H. Ishiwata et al.

    Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction

    Neuroscience

    (2005)
  • A.A. Salari et al.

    Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring

    Behav. Brain Res.

    (2016)
  • C. Dalla et al.

    Sex differences in learning processes of classical and operant conditioning

    Physiol. Behav.

    (2009)
  • S.J. Alonso et al.

    Sex differences in behavioral despair: relationships between behavioral despair and open field activity

    Physiol. Behav.

    (1991)
  • J.A. Babb et al.

    Sex differences in activated corticotropin-releasing factor neurons within stress-related neurocircuitry and hypothalamic-pituitary-adrenocortical axis hormones following restraint in rats

    Neuroscience

    (2013)
  • M.Q. Steinman et al.

    Hypothalamic vasopressin systems are more sensitive to the long term effects of social defeat in males versus females

    Psychoneuroendocrinology

    (2015)
  • M.L. Gomez et al.

    Influence of the brain sexual differentiation process on despair and antidepressant-like effect of fluoxetine in the rat forced swim test

    Neuroscience

    (2014)
  • K. Lebron-Milad et al.

    Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction

    Behav. Brain Res.

    (2013)
  • A.T. Behan et al.

    vidence of female-specific glial deficits in the hippocampus in a mouse model of prenatal stress

    Eur. Neuropsychopharm.

    (2011)
  • J.L. Pawluski et al.

    Stress and the pregnant female: Impact on hippocampal cell proliferation, but not affective-like behaviors

    Horm. Behav.

    (2011)
  • B.R. Mueller et al.

    Early prenatal stress impact on coping strategies and learning performance is sex dependent

    Physiol. Behav.

    (2007)
  • P.d.N. Favaro et al.

    Maternal fluoxetine treatment decreases behavioral response to dopaminergic drugs in female pups

    Neurotoxicol. Teratol.

    (2008)
  • A.J. Grippo et al.

    Behavioral and cardiovascular changes in the chronic mild stress model of depression

    Physiol. Behav.

    (2003)
  • J. Archer

    Tests for emotionality in rats and mice: a review

    Anim. Behav.

    (1973)
  • B.B. McAllister et al.

    Behavioural outcomes of perinatal maternal fluoxetine treatment

    Neuroscience

    (2012)
  • S. Hogg

    A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

    Pharmacol. Biochem. Behav.

    (1996)
  • A.P. Cruz et al.

    Ethopharmacological analysis of rat behavior on the elevated plus-maze

    Pharmacol. Biochem. Behav.

    (1994)
  • R.J. Rodgers et al.

    Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

    Pharmacol. Biochem. Behav.

    (1995)
  • D.K. Kinney et al.

    Prenatal stress and risk for autism

    Neurosci. Biobehav. R.

    (2008)
  • S.L. Kjaer et al.

    Prenatal and adult stress interplay--behavioral implications

    Brain Res.

    (2010)
  • C. Zhao et al.

    Mechanisms and functional implications of adult neurogenesis

    Cell

    (2008)
  • A.R. Gobinath et al.

    Maternal postpartum corticosterone and fluoxetine differentially affect adult male and female offspring on anxiety-like behavior, stress reactivity, and hippocampal neurogenesis

    Neuropharmacology

    (2016)
  • M. Nagano et al.

    Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone

    Neuropharmacology

    (2012)
  • N.I. Gavin et al.

    Perinatal depression - A systematic review of prevalence and incidence

    Obstetr. Gynecol.

    (2005)
  • T. Kitamura et al.

    Psychological and social correlates of the onset of affective-disorders among pregnant-women

    Psychol. Med.

    (1993)
  • L.E. Ross et al.

    Anxiety disorders during pregnancy and the postpartum period: A systematic review

    J. Clin. Psychiatry

    (2006)
  • S.E. Hobfoll et al.

    Depression prevalence and incidence among inner-city pregnant and postpartum women

    J. Consulting Clin. Psychol.

    (1995)
  • C. Borri et al.

    Axis I psychopathology and functional impairment at the third month of pregnancy: Results from the Perinatal Depression-Research and Screening Unit (PND-ReScU) study

    J. Clin. Psychiatry

    (2008)
  • J. Alder et al.

    Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome?. A critical review of the literature

    J. Matern Fetal Neonatal. Med.

    (2007)
  • C. Dunkel Schetter et al.

    Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice

    Curr. Opin. Psychiatry

    (2012)
  • R. Mandrioli et al.

    Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions

    Curr. Med. Chem.

    (2012)
  • S.E. Andrade et al.

    Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program

    (2016)
  • C.D. Chambers et al.

    Birth outcomes in pregnant women taking fluoxetine

    N. Engl. J. Med.

    (1996)
  • Cited by (25)

    • Prenatal stress and fluoxetine exposure in mice differentially affect repetitive behaviors and synaptic plasticity in adult male and female offspring

      2023, Behavioural Brain Research
      Citation Excerpt :

      Using the elevated plus-maze, we found that our prenatal manipulations did not lead to anxiety-like behavior in either female or male offspring. Numerous studies have investigated how maternal stress during pregnancy along with anti-depressant treatments effects anxiety-like behavior in offspring using the elevated plus-maze [89,104,105,108–111]. There have been several different patterns of results that appear to vary based on the use of rats versus mice and what strain of mice is used.

    • Semax, synthetic ACTH(4–10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats

      2021, Neuropeptides
      Citation Excerpt :

      However, perinatal sertraline administration did not have any effect on spatial learning in mice (Meyer et al., 2018). Kiryanova and co-authors reported improvements in spatial learning, but not avoidance behaviour in adult rats perinatally exposed to fluoxetine (Kiryanova et al., 2017; Kiryanova and Dyck, 2014). In our work, we used the model of egocentric route-based learning in a maze with food reinforcement.

    View all citing articles on Scopus
    View full text